-
A group of experts in areas ranging from medicine to law and bioethics suggests that a base of quality evidence must exist and associated ethical concerns must be addressed before public health strategies based on genomics are implemented.
-
The focus of The Schwartz Center for Compassionate Healthcare's programming is something called The Schwartz Center Rounds, which would have a familiar ring to most clinicians.
-
When CIGNA members being treated by Piedmont Physicians Group in Atlanta are high-risk or noncompliant, Jennifer Farlow, RN, BSN, clinical care coordinator, contacts them and helps them get back on track for regular visits and recommended tests and procedures.
-
Who knew what when? At times, you can be put in a tough position because of what a worker tells you. "We are not safety and we can't discipline, so employees tend to tell us more than they would tell others," says Susan L. Zarzycki, RN,COHN,CM, an occupational health manager at Finch Paper LLC in Glens Falls, NY. Here are some common scenarios and how to deal with each:
-
As health care organizations tighten their belts to deal with today's health care environment, case managers report working harder with fewer raises and benefits. But, there is hope on the horizon as new opportunities open up for case managers under health care reform, experts say.
-
As talk of reimbursement reform and pay for performance escalates and health care stakeholders look at ways to improve patient access and outcomes while reducing waste and costs, payers and providers are joining together to create accountable care organizations (ACOs), partnerships that agree to be accountable for the quality, costs, and overall care of a patient population.
-
Use of alcohol-based hand cleansers significantly reduced several common infections and reduced absenteeism in a study of 129 white-collar workers in 2005 to 2006, according to research from the Institute of Hygiene and Environmental Medicine in Greifswald, Germany.
-
As institutions continue to weather the economic downturn, the toll on IRB offices is showing. The trends of previous years fewer raises, more job cuts, increasing workloads continued in 2010, according to responses to IRB Advisor's annual Salary Survey.
-
Recruiting patients for Phase I oncology studies which are unlikely to provide therapeutic benefit to participants and which carry the risk of significant side effects raises unique issues in informed consent.
-
As more sophisticated imaging technologies are used in research, investigators and IRBs must grapple with an unintended side effect an increase in incidental findings (IF), or new health data unrelated to the study that is revealed about participants.
